The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV
Latest Information Update: 15 Oct 2024
At a glance
- Drugs Cabotegravir+rilpivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms EXPAND
- 15 Oct 2024 New trial record